Inhibition of protein disulfide isomerases as a strategy for reduction of prothrombotic state in atherosclerosis; therapeutic implications
2021/43/D/NZ7/03366
Keywords
Descriptors
- NZ7_014: Farmacja, farmakoterapia, farmakologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 5
Call
SONATA 17 – announced on 2021-09-15
- Amount awarded
- 1 657 204 PLN
- Project start date
- 2022-08-03
- Project end date
- 2026-08-02
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Protein disulfide isomerase 1 (PDIA1) regulates platelet-derived extracellular vesicle release
- Authors:
- Agnieszka Pelesz ,Katarzyna Rafa-Zablocka, Patrycja Kaczara, Stefan Chlopicki, Kamil Przyborowski
- Academic press:
- Thrombosis Research (year: 2025, volume: 245:109209, pages: 46033), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.thromres.2024.109209 – link to the publication